AHFS DI Monographs

The American Hospital Formulary Service Drug Information (AHFS DI), published by the American Society of Health-System Pharmacists (ASHP), is the leading comprehensive source of authoritative and unbiased drug information for health professionals.

A wholly independent team of drug-information pharmacists, alongside editorial and analytical experts, conducts thorough research for all AHFS DI content. The publication incorporates peer-reviewed clinical research, therapeutic guidelines, and Food and Drug Administration (FDA)-approved labeling to provide evidence-based monographs for safe and effective drug therapy.

About AHFS DI Monographs

The U.S. Congress and major healthcare insurance providers have recognized the authority of AHFS DI for determining medically accepted drug uses. The publication has been designated by the American College of Physicians–American Society of Internal Medicine as a standard reference for medical libraries and is a required drug reference for pharmacies in most states. The publication maintains strict editorial independence from pharmaceutical manufacturers, health insurers, pharmacy benefit managers, and other third parties, a policy formally endorsed by the ASHP Board of Directors.

AHFS DI monographs incorporate authoritative recommendations from the U.S. Centers for Disease Control and Prevention (CDC), American Heart Association (AHA), Institute of Medicine of the National Academies, and the Women's Health Initiative. The publication integrates critical safety information from FDA MedWatch and presents the latest scientific developments in drug therapy.